The General Assembly finds that certain practices are unfair to providers of pharmaceuticals, are burdensome and costly to those providers, result in unfair increased costs to certain consumers, and threaten the availability of pharmaceuticals to the public. The General Assembly further finds that there is a need for regulation of certain practices engaged in by some third-party prescription program administrators.
Section: 26-4-140 26-4-141 26-4-142 26-4-143 26-4-144 26-4-145 26-4-146 26-4-147 26-4-148 NextLast modified: October 14, 2016